Pharma's Almanac TV
PA TV
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Investment
161 Articles Available
1
7
Can't find what you're looking for? Try our
advanced search
.
Investment
Governor Cooper Announces Over 460 Jobs in Durham as Eli Lilly and Company Selects North Carolina for Major Pharmaceutical Plant
PR-M01-20-NI-034
Financing
JOINN Biologics Inc. Receives $60 Million Series A Financing
PR-M12-19-NI-036
Funding
Akoya Biosciences Raises $50 Million in New Financing
PR-M12-19-NI-010
Gene Therapy
Ferring and Blackstone Life Sciences Invest Over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients
PR-M11-19-NI-032
Investment
Lilly Announces $400 Million Capital Investment in Manufacturing Facilities in Indianapolis
PR-M11-19-NI-028
Cell and Gene Therapy
FUJIFILM Diosynth Biotechnologies Announces $55 Million Investment to Expand Gene Therapy Development Capabilities
PR-M11-19-NI-013
Investment
Boehringer Ingelheim Invests Nearly $50 Million to Expand Plant in Puerto Rico
PR-M11-19-NI-014
Executive Compensation
Executive Compensation: Essential Factor in Private Equity Transactions
PAP-Q3-19-CL-007
Funding
Sofinnova Partners Raises €333 Million Capital IX Early-Stage Healthcare Fund
PR-M10-19-NI-027
Investment
PCI Strengthens Position in Europe with Investment in Ireland
PR-M09-19-NI-016
Investment
Rumors Suggest Amgen is Interested in Alexion
PAO-M00-19-NI-001
Investment
Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina
PR-M08-19-NI-079
Financing
Juvenescence Completes $100 Million Series B Financing Round
PAO-M08-19-NI-035
Investment
The Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance
PR-M08-19-NI-072
Expansion
Announcing Expansion for Enhanced Capabilities
PTV-M08-19-BIO-004
Investment
Rakuten Medical Secures Additional Investment from Rakuten to Further Develop its Photoimmunotherapy Platform Capabilities
PR-M08-19-NI-013
Funding
Wellington Partners Raises EUR 210 Million Life Science Fund
PR-M08-19-NI-002
M&A
EQT to Acquire Majority Interest in Aldevron – the Leading Global Supplier of Plasmid DNA Used in Cell and Gene Therapies
PR-M07-19-NI-081
Market Growth
Sanofi Delivered Solid Growth in Q2 2019
PR-M07-19-NI-077
Growth
Lonza on Track to Deliver Full-Year 2019 Results, Driven by Pharma Biotech Business
PR-M07-19-NI-069
Financing
ADC Therapeutics Announces Final Close of Series E Financing Expansion
PR-M07-19-NI-029
Financing
IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline
PR-M07-19-NI-028
Funding
Esperion Raises an Additional $200 Million
PAO-M07-19-NI-015
Funding
Esperion and Oberland Capital Announce $200 Million Funding Agreement
PR-M07-19-NI-007
1
7
»
